This statistic shows a projection of the top 25 global pharmaceutical products and their respective revenues worldwide in 2024. AbbVie's and Eisai's Humira is expected to generate some 15.2 billion U.S. dollars in revenue by 2024.
- Health & Pharmaceuticals›
- Pharmaceutical Products & Market›
Leading 25 global pharmaceutical products and respective revenues 2024
Premium statistics
Industry-specific and extensively researched technical data (partially from exclusive partnerships).
A paid subscription is required for full access.
Projected top 25 global pharmaceutical products by revenue in 2024 (in million U.S. dollars)
Exclusive Premium Statistic
This statistic shows a projection of the top 25 global pharmaceutical products and their respective revenues worldwide in 2024. AbbVie's and Eisai's Humira is expected to generate some 15.2 billion U.S. dollars in revenue by 2024.
| Product (Company) | Revenue in million U.S. dollars |
|---|---|
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| Product (Company) | Revenue in million U.S. dollars |
|---|---|
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
Exclusive Premium statistic
You need a Premium Account for unlimited access.
Full access to 1.5m statistics
Incl. source references
Available to download in PNG, PDF, XLS format
Exclusive content
Exclusive Premium statistic
You need a Premium Account for unlimited access.
Full access to 1.5m statistics
Incl. source references
Available to download in PNG, PDF, XLS format
About this statistic
Show source
Download
Settings
Share
Chart type
Datalabels
Share on Social Media
Download started
Please be patient - this may take a moment
Please be patient - this may take a moment
Description
Source
More information
This statistic shows a projection of the top 25 global pharmaceutical products and their respective revenues worldwide in 2024. AbbVie's and Eisai's Humira is expected to generate some 15.2 billion U.S. dollars in revenue by 2024.
Show more- Show sources information
- Show publisher information
- Release date
- June 2018
- Region
- Worldwide
- Survey time period
- as of May 2018
- Supplementary notes
- Sales represent company reported sales where available, otherwise based on an average of equity analyst estimates.
More information
- Region
- Worldwide
- Survey time period
- as of May 2018
- Supplementary notes
- Sales represent company reported sales where available, otherwise based on an average of equity analyst estimates.
Other interesting statistics
+
+2018 list of global top 10 biotech and pharmaceutical companies based on net income
+
+Total global pharmaceutical R&D spending 2010-2024
+
+World pharmaceutical sales 2015-2017 by region
+
+Top therapeutic classes by global pharmaceutical sales 2017 estimates
+
+Top 50 pharmaceutical companies - Rx sales and R&D spending 2017
+
+Top 10 biotech and pharmaceutical companies based on market cap 2018
Statista Accounts: Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account!
Premium Account
Your perfect start with Statista
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$49 / Month *
Corporate Account
Full access
Corporate solution including all features.
* All products require an annual contract.
Prices do not include sales tax
(New York residents only).
Prices do not include sales tax
(New York residents only).
Leading companies trust Statista:
Related Studies: Available to Download in PDF or PPTX Format
All Information
in one Presentation
Global pharmaceutical industry
- 81 page/s
- English
- pptx
- Detailed references
Everything On "Global pharmaceutical industry" in One Document: Edited and Divided into Handy Chapters. Including Detailed References.
Statista is a great source of knowledge, and pretty helpful to manage the daily work.Christof Baron
CEO, MindShare Germany
Statistics on "Global pharmaceutical industry"
- Overview
The most important statistics
- Revenue of the worldwide pharmaceutical market from 2001 to 2017 (in billion U.S. dollars)Pharmaceutical market: worldwide revenue 2001-2017
- Distribution of global pharmaceutical market revenue from 2010 to 2017, by regionGlobal pharmaceutical market - revenue distribution 2010-2017 by region
- Global pharmaceutical sales from 2015 to 2017, by region (in billion U.S. dollars)*World pharmaceutical sales 2015-2017 by region
- Distribution of the total global pharmaceutical market sales from 2014 to 2017, by submarket*World pharmaceutical market distribution by submarket 2014-2017
- Growth of top 10 national pharmaceutical markets worldwide from 2012 to 2017*Top 10 global pharmaceutical markets: growth 2012-2017
- Top 10 therapeutic classes by estimated global pharmaceutical sales in 2017 (in billion U.S. dollars)Top therapeutic classes by global pharmaceutical sales 2017 estimates
- Global spending growth in selected pharmaceutical major therapeutic classes between 2012 and 2017*Spending growth of top pharmaceutical therapeutic classes by CAGR 2012-2017
- Companies and products
The most important statistics
- Top 50 global pharmaceutical companies by prescription sales and R&D spending in 2017 (in billion U.S. dollars)Top 50 pharmaceutical companies - Rx sales and R&D spending 2017
- 2018 ranking of the global top 10 biotech and pharmaceutical companies based on net income (in billion U.S. dollars)2018 list of global top 10 biotech and pharmaceutical companies based on net income
- Top 10 biotech and pharmaceutical companies worldwide based on market capitalization as of 2018 (in billion U.S. dollars)Top 10 biotech and pharmaceutical companies based on market cap 2018
- Top 15 pharmaceutical products by sales worldwide in 2017 (in million U.S. dollars)Top pharmaceutical products by sales worldwide 2017
- Top generics manufacturers based on revenue in 2016 (in billion U.S. dollars)*Revenues of leading global generics manufacturers 2016
- Top 10 cancer drugs worldwide by revenue in 2017 (in billion U.S. dollars)Top cancer drugs based on revenue worldwide 2017
- World's top 50 pharmaceutical and biotechnology companies based on capital expenditure growth in 2017/2018Top pharmaceutical companies by capex growth in 2017/2018
- Top companies by revenue
The most important statistics
- Novartis AG's total revenue from 2007 to 2018 (in billion U.S. dollars)Novartis' revenue 2007-2018
- Novartis AG's revenue from 2014 to 2018, by segment (in billion U.S. dollars)Novartis revenue 2014-2018 by segment
- Pfizer's total revenue from 2006 to 2017 (in million U.S. dollars)Pfizer's total revenue 2006-2017
- Pfizer's revenue in 2014 and 2017, by segment (in million U.S. dollars)*Pfizer's revenue by segment 2014-2017
- Total sales of the Roche Group from 2006 to 2018 (in million Swiss francs)Roche Group's total sales 2006-2018
- Total sales of the Roche Group from 2013 to 2018, by division (in million Swiss francs)Roche Group's total sales by division 2013-2018
- R&D, patents, new products
The most important statistics
- Total global spending on pharmaceutical research and development from 2010 to 2024 (in billion U.S. dollars)Total global pharmaceutical R&D spending 2010-2024
- Global top 10 pharmaceutical companies based on projected R&D spending in 2024 (in billion U.S. dollars)Global top pharmaceutical companies based on R&D spending 2024
- Worldwide total prescription drug revenue at risk from patent expiration from 2010 to 2024 (in billion U.S. dollars)*Patent expiration risks for total worldwide prescription drug revenue 2010-2024
- Percentage of global prescription drug revenue at risk from patent expiration from 2010 to 2024Worldwide prescription drug revenue - market risk from patent expiration 2010-2024
- Small molecules sales at risk due to patent expirations in the U.S. from 2009 to 2022 (in billion U.S. dollars)Projected sales at risk due to patent expiry 2009-2022
- Leading pharmaceutical companies based on sales loss due to patent risk until year-end 2018Top pharma companies by sales loss due to patent loss until 2018
- Number of new chemical or biological entities developed between 1992 and 2017, by region of originPharmaceutical industry - number of new substances 1992-2017
- Total number of novel drugs approved by CDER from 2008 to 2018Number of novel drugs approved annually by CDER 2008-2018
- Outlook
The most important statistics
- Projected global pharmaceutical sales for 2021, by region (in billion U.S. dollars)*World pharmaceutical sales by region forecast 2021
- Worldwide forecast of pharmaceutical sector growth between 2017 and 2030, by countryPharmaceutical sector growth worldwide 2017-2030, by country
- Global spending on medicines from 2010 to 2022 (in billion U.S. dollars)Global spending on medicines 2010-2022
- Projected expenditure on medicine of selected countries worldwide in 2022 (in billion U.S. dollars)Country spending on medicine 2022
- Projected top 25 global pharmaceutical products by revenue in 2024 (in million U.S. dollars)Leading 25 global pharmaceutical products and respective revenues 2024
- Global top 10 pharmaceutical companies based on projected R&D spending in 2024 (in billion U.S. dollars)Global top pharmaceutical companies based on R&D spending 2024
Popular Related Keywords
- revenue
- forecast
- pharmaceutical products
- top brands
- Show more
Need help with using Statista for your research? Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Statistics
- Leading global anti-viral products by market share 2017 and 2024
- 3 year average R&D cost to develop new pharmaceutical compounds 2010-2018
- Members of EFPIA's pharmaceutical exports and imports 1990-2017
- Leading European vaccine products by market share 2015-2022
- R&D cost to develop new pharmaceutical compounds 2010-2018
- Top U.S. proton pump inhibitors' revenue market share 2013
- Top U.S. cholesterol-lowering drugs by revenue market share 2013
- Top U.S. proton pump inhibitors based on prescriptions 2013
- Top U.S. proton pump inhibitors market share based on prescriptions 2013
- Top U.S. proton pump inhibitors based on revenue 2013
- U.S. consumer feelings about direct-to-consumer pharmaceutical ads in 2017
- Top new orphan molecular entities by U.S. sales in 2019
- Italy: number of biotech orphan drugs drugs marketed 2016-2017, by type
- Italy: number of biotech projects along the drug pipeline 2016-2017, by area
- Share of costs to R&D of Novo Nordisk 2007-2017
- Belgium: bile and other animal glands for pharmaceutical preparation 2012-2017
- Top-of-mind probiotic yoghurt brands South Korea 2017
- Manufacture of basic pharmaceutical products revenue in France 2010-2022
- Spain: medicament mixtures put in dosage import value 2013-2017
- Italy: growth rate of advanced dressings market value 2017-2018, by segment
Studies
- Meds Entry Watch 2016
- Prescribed Drug Spending in Canada, 2018
- Pharmaceutical trends in Europe
- Drug Use Among Seniors in Canada, 2016
- Patented Medicine Prices Review Board - Annual Report 2017
- Trends in Retail Prices of Prescription Drugs Widely Used by Older Americans: 2006 to 2015
- Compass Rx - Annual Public Drug Plan Expenditure Report 2015/16
- Patented Medicine Prices Review Board - Annual Report 2016
- Prescribed Drug Spending in Canada, 2017
- PAGB Annual Review 2017-2018
- Compass Rx - Annual Public Drug Plan Expenditure Report 2012/13
- Prescription drug access and affordability an issue for nearly a quarter of all Canadian h...
- Prescribed Drug Spending in Canada, 2013
- Patented Medicine Prices Review Board - Annual Report 2013
- Patented Medicine Prices Review Board - Annual Report 2014
Statistics on the topic
Free statistics
- Top 15 pharmaceutical products by sales worldwide in 2017 (in million U.S. dollars)
- Percentage of global prescription drug revenue at risk from patent expiration from 2010 to 2024
- Small molecules sales at risk due to patent expirations in the U.S. from 2009 to 2022 (in billion U.S. dollars)
- Worldwide forecast of pharmaceutical sector growth between 2017 and 2030, by country
- Projected expenditure on medicine of selected countries worldwide in 2022 (in billion U.S. dollars)
- Three-year average R&D cost to develop a pharmaceutical compound from discovery to launch from 2010 to 2018, by study cohort (in billion U.S. dollars)
- Top 3 European vaccine products in 2015 and 2022 by market share
- Average R&D cost to develop a pharmaceutical compound from discovery to launch from 2010 to 2018, by study cohort (in billion U.S. dollars)
- Top proton pump inhibitors based on U.S. revenue market share in 2013
- Top HMG-CoA reductase inhibitors based on U.S. revenue market share in 2013
- Top proton pump inhibitors based on U.S. prescriptions market share in 2013
- Percentage of U.S. consumers that felt select ways about direct-to-consumer (DTC) ads that address patient knowledge as of 2017
- Value of medicament mixtures put in dosage imported to Spain from 2013 to 2017 (in 1,000 euros)
Premium Statistics
- Revenue of the worldwide pharmaceutical market from 2001 to 2017 (in billion U.S. dollars)
- Distribution of global pharmaceutical market revenue from 2010 to 2017, by region
- Global pharmaceutical sales from 2015 to 2017, by region (in billion U.S. dollars)*
- Distribution of the total global pharmaceutical market sales from 2014 to 2017, by submarket*
- Growth of top 10 national pharmaceutical markets worldwide from 2012 to 2017*
- Top 10 therapeutic classes by estimated global pharmaceutical sales in 2017 (in billion U.S. dollars)
- Global spending growth in selected pharmaceutical major therapeutic classes between 2012 and 2017*
- Top 50 global pharmaceutical companies by prescription sales and R&D spending in 2017 (in billion U.S. dollars)
- 2018 ranking of the global top 10 biotech and pharmaceutical companies based on net income (in billion U.S. dollars)
- Top 10 biotech and pharmaceutical companies worldwide based on market capitalization as of 2018 (in billion U.S. dollars)
- Top generics manufacturers based on revenue in 2016 (in billion U.S. dollars)*
- Top 10 cancer drugs worldwide by revenue in 2017 (in billion U.S. dollars)
- World's top 50 pharmaceutical and biotechnology companies based on capital expenditure growth in 2017/2018
- Novartis AG's total revenue from 2007 to 2018 (in billion U.S. dollars)
- Novartis AG's revenue from 2014 to 2018, by segment (in billion U.S. dollars)
- Pfizer's total revenue from 2006 to 2017 (in million U.S. dollars)
- Pfizer's revenue in 2014 and 2017, by segment (in million U.S. dollars)*
- Total sales of the Roche Group from 2006 to 2018 (in million Swiss francs)
- Total sales of the Roche Group from 2013 to 2018, by division (in million Swiss francs)
- Total global spending on pharmaceutical research and development from 2010 to 2024 (in billion U.S. dollars)
- Global top 10 pharmaceutical companies based on projected R&D spending in 2024 (in billion U.S. dollars)
- Worldwide total prescription drug revenue at risk from patent expiration from 2010 to 2024 (in billion U.S. dollars)*
- Leading pharmaceutical companies based on sales loss due to patent risk until year-end 2018
- Number of new chemical or biological entities developed between 1992 and 2017, by region of origin
- Total number of novel drugs approved by CDER from 2008 to 2018
- Top biotech and pharma product launches in 2018 and revenue forecast for 2022 (in million U.S. dollars)
- Projected global pharmaceutical sales for 2021, by region (in billion U.S. dollars)*
- Global spending on medicines from 2010 to 2022 (in billion U.S. dollars)
- Projected top 25 global pharmaceutical products by revenue in 2024 (in million U.S. dollars)
- Top 5 global anti-viral products by market share in 2017 and 2024
- Pharmaceutical imports and exports of EFPIA members from 1990 to 2017 (in million euros)
- Top 10 proton pump inhibitors based on U.S. prescriptions in 2013 (in millions)
- Top proton pump inhibitors based on U.S. revenue in 2013 (in million U.S. dollars)
- Leading new orphan molecular entities by U.S. sales in 2014 and 2019 (in million U.S. dollars)*
- Number of biotech orphan drugs marketed in Italy between 2016 and 2017, by type (in units)
- Number of biotech projects along the drug pipeline in Italy between 2016 and 2017, by therapeutic area
- Share of costs spent on research and development of Novo Nordisk from 2007 to 2017
- Value of bile and other animal glands for pharmaceutical preparation exported from Belgium from 2012 to 2017 (in 1,000 euros)
- Top-of-mind awareness of probiotic yoghurt brands in South Korea as of March 2017
- Manufacture of basic pharmaceutical products revenue in France from 2010 to 2022 (in million U.S. dollars)
- Annual growth rate of advanced dressings market value in Italy from 2017 to 2018, by segment*
Statista Accounts: Access All Statistics. Starting from $588 / Year
Topics
About Statista
Statista offers dossiers and reports on over 170 industries. With Statista you are always able to make informed decisions and boost your work efficiency.
Internet & Telecommunications
- Social Media
- E-Commerce
- Online Video & Entertainment
- Advertising & Marketing
Consumer Goods & FMCG
- Alcoholic Beverages
- Cleaning Products
- Cosmetics & Personal Care
- Food & Nutrition
Retail & Trade
- Health & Hygiene
- International Trade
- Shopping Behavior
- Sports & Leisure
Travel, Tourism & Hospitality
- Business Travel
- Leisure Travel
- Accomodation
- Restaurants
Society
- Demographics
- Economy
- Education & Science
- Politics & Government
Transportation & Logistics
- Aviation
- Rail Transport
- Vehicles & Road Traffic
- Water Transport
Save statistic in .XLS format
You can only download this statistic as a Premium user.
Save statistic in .PNG format
You can only download this statistic as a Premium user.
Save statistic in .PDF format
You can only download this statistic as a Premium user.
Show source references
As a Premium user you get access to the detailed source references and background information about this statistic.
Show details about this statistic
As a Premium user you get access to background information and details about the release of this statistic.
Bookmark statistics
As soon as this statistic is updated, you will immediately be notified via e-mail.
Change statistics options
You need at least a Premium Account to use this feature.
Exclusive Corporate feature
This feature is limited to our corporate solutions.
Please contact us to get started with full access to dossiers, forecasts, studies and international data.
Corporate Account
News
News
Latest News
New
New Dossier: United States coal mining industry
U.S. coal production has steadily declined in the past decade, but has been in the news in recent years due to President Trump's desire to revitalize the industry. This document provides an overview of the key figures, leading companies, and the employment trends in the U.S. coal mining industry.
New
Global Consumer Survey offers PowerPoint export
This new export feature offers
- Structured graphical representation of the data
- Tailored target group analysis
- Option for further processing
New
New Dossier: E-commerce in Poland
The Polish e-commerce market is one of the fastest developing e-commerce markets in Europe. The latest data for Poland is presented in this dossier.
New
New Dossier: Plastic waste in the U.S.
Plastic waste is an issue of global concern. Since China banned the import of recycled plastic, the U.S. has had to make adjustments to its management of plastic waste. This dossier provides an overview of plastic waste in the U.S.
New
New Dossier: Hedge funds
This dossier provides an overview of hedge funds worldwide. Global hedge fund assets, performance, investors, and other topics are highlighted.
New
New exclusive OOH advertising data by OAAA
The Outdoor Advertising Association of America covers amongst others
- Number of billboards
- Outdoor advertising revenue
- Number of out-of-home displays
New
What happens after a no-deal Brexit?
Find data, perceptions & more about
- Economic consequences
- Impact on the labor market
- A second referendum
New
ecommerceDB.com: Ranking update – Spain
Understand the recent developments in the Spanish eCommerce market!
- URL-related revenues
- Relevant online store KPIs
- eCommerce-related contacts
New
Insights into the European banking sector
- Extended statistical dossier
- Insights, explanations & interpretations
- Challenges of the digital future
New
Dossier: Latin American online shopping events
eCommerce is rapidly becoming a part of the Latin American shopping culture. The dossier includes data on
- Regional online shopping events
- Events by country
Updated
Updated Brexit analysis in UK Industry Reports
The outline of potential impacts of Brexit on UK industries has been updated in the UK Industry Reports.
New
New Dossier: Digital Marketing in Italy
Italian enterprises invest significantly in digital marketing. Find out about
- Relevant aspects & KPIs
- New trends
- Different strategies
New
What is football all about, anyway?
Statista European Football Benchmark
- The big 5 European leagues
- All about the clubs & fans
- Sponsors & how they fit in
New
Payment methods in eCommerce
What are online shoppers' payment preferences around the world?
- Data on all payment methods
- Analysis for 50 countries
- Forecasts up to 2023
New
New Dossier: Foreign conflicts of Saudi Arabia
The kingdom of Saudi Arabia has faced political challenges.
- Perceptions & trade information
- Conflicts with Yemen, Iran, Qatar & Turkey
We use cookies to personalize contents and ads, offer social media features, and analyze access to our website. In your browser settings you can configure or disable this, respectively, and can delete any already placed cookies. For details, please see your browser’s Help section (by pressing F1). Please see our privacy statement for details about how we use data.